1 Sinn, D. H. et al. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. The American journal of gastroenterology107, 561-567, doi:10.1038/ajg.2011.400 (2012).
2 Speliotes, E. K. et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology51, 1979-1987, doi:10.1002/hep.23593 (2010).
3 Targher, G., Day, C. P. & Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. The New England journal of medicine363, 1341-1350, doi:10.1056/NEJMra0912063 (2010).
4 Ong, J. P., Pitts, A. & Younossi, Z. M. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. Journal of hepatology49, 608-612, doi:10.1016/j.jhep.2008.06.018 (2008).
5 Stepanova, M. & Younossi, Z. M. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association10, 646-650, doi:10.1016/j.cgh.2011.12.039 (2012).
6 Stenholm, S. et al. Obesity and muscle strength as long-term determinants of all-cause mortality--a 33-year follow-up of the Mini-Finland Health Examination Survey. International journal of obesity38, 1126-1132, doi:10.1038/ijo.2013.214 (2014).
7 Chuang, S. Y., Hsu, Y. Y., Chen, R. C., Liu, W. L. & Pan, W. H. Abdominal Obesity and Low Skeletal Muscle Mass Jointly Predict Total Mortality and Cardiovascular Mortality in an Elderly Asian Population. The journals of gerontology. Series A, Biological sciences and medical sciences71, 1049-1055, doi:10.1093/gerona/glv192 (2016).
8 Rasmussen, B. B. et al. Insulin resistance of muscle protein metabolism in aging. FASEB journal : official publication of the Federation of American Societies for Experimental Biology20, 768-769, doi:10.1096/fj.05-4607fje (2006).
9 Takamura, T., Misu, H., Ota, T. & Kaneko, S. Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver. Endocrine journal59, 745-763 (2012).
10 Cesari, M. et al. Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. The American journal of clinical nutrition82, 428-434 (2005).
11 Kalyani, R. R., Corriere, M. & Ferrucci, L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. The lancet. Diabetes & endocrinology2, 819-829, doi:10.1016/S2213-8587(14)70034-8 (2014).
12 Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital and health statistics. Ser. 1, Programs and collection procedures, 1-407 (1994).
13 Batsis, J. A. et al. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004. Journal of the American Geriatrics Society61, 974-980, doi:10.1111/jgs.12260 (2013).
14 Yue, W., Sun, X. & Du, T. Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition Examination Survey. BMC endocrine disorders19, 95, doi:10.1186/s12902-019-0423-y (2019).
15 Lazo, M. et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. Bmj343, d6891, doi:10.1136/bmj.d6891 (2011).
16 Janssen, I., Heymsfield, S. B. & Ross, R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. Journal of the American Geriatrics Society50, 889-896 (2002).
17 Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and ageing39, 412-423, doi:10.1093/ageing/afq034 (2010).
18 Cooper, R. et al. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. Bmj341, c4467, doi:10.1136/bmj.c4467 (2010).
19 Toma, M. et al. Transition from meeting abstract to full-length journal article for randomized controlled trials. Jama295, 1281-1287, doi:10.1001/jama.295.11.1281 (2006).
20 Abellan van Kan, G. et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. The journal of nutrition, health & aging13, 881-889 (2009).
21 Guralnik, J. M. et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. The journals of gerontology. Series A, Biological sciences and medical sciences55, M221-231 (2000).
22 Studenski, S. et al. Gait speed and survival in older adults. Jama305, 50-58, doi:10.1001/jama.2010.1923 (2011).
23 National Center for Health Statistics. The Third National Nutrition and Health Survey Linked Mortality File: Matching Methodology. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention (2006).
24 World Health Organization. ICD-10: international statistical classification of diseases and related health problems: tenth revision. (2004).
25 Shah, A. G. et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association7, 1104-1112, doi:10.1016/j.cgh.2009.05.033 (2009).
26 Angulo, P. et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology45, 846-854, doi:10.1002/hep.21496 (2007).
27 Wai, C. T. et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology38, 518-526, doi:10.1053/jhep.2003.50346 (2003).
28 Xiao, J., Purcell, S. A., Prado, C. M. & Gonzalez, M. C. Fat mass to fat-free mass ratio reference values from NHANES III using bioelectrical impedance analysis. Clinical nutrition37, 2284-2287, doi:10.1016/j.clnu.2017.09.021 (2018).
29 Golabi, P. et al. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. BMC gastroenterology19, 56, doi:10.1186/s12876-019-0972-6 (2019).
30 Tallarico, V. et al. Prognostic value of non-alcoholic fatty liver disease in the elderly patients. Aging clinical and experimental research, doi:10.1007/s40520-020-01487-2 (2020).
31 Kim, D., Kim, W. R., Kim, H. J. & Therneau, T. M. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology57, 1357-1365, doi:10.1002/hep.26156 (2013).
32 Angulo, P. et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology149, 389-397 e310, doi:10.1053/j.gastro.2015.04.043 (2015).
33 Lee, Y. H. et al. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011). Hepatology63, 776-786, doi:10.1002/hep.28376 (2016).
34 Angulo, P. Nonalcoholic fatty liver disease. The New England journal of medicine346, 1221-1231, doi:10.1056/NEJMra011775 (2002).
35 Valero, V., 3rd et al. Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract19, 272-281, doi:10.1007/s11605-014-2680-4 (2015).
36 Yarasheski, K. E. Managing sarcopenia with progressive resistance exercise training. The journal of nutrition, health & aging6, 349-356 (2002).
37 Hong, H. C. et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology59, 1772-1778, doi:10.1002/hep.26716 (2014).
38 Bostrom, P. et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature481, 463-468, doi:10.1038/nature10777 (2012).
39 Wu, C., Smit, E., Peralta, C. A., Sarathy, H. & Odden, M. C. Functional Status Modifies the Association of Blood Pressure with Death in Elders: Health and Retirement Study. Journal of the American Geriatrics Society65, 1482-1489, doi:10.1111/jgs.14816 (2017).